Clinical Trials
497 articles
Participating in clinical trials can give you access to the latest treatments for pancreatic cancer.
A New Immunotherapy Combination for Metastatic Pancreatic Cancer
Researchers are looking at a combination of two types of monoclonal antibodies to treat advanced pancreatic cancer.
Pancreatic Cancer and Family History
Dr. Diane Simeone is developing a tablet-based family history survey to identify patients with a genetic-based risk for developing pancreatic cancer.
Neoantigens Provide New Hope for Pancreatic Cancer Treatments
Vinod Balachandran’s team identified increased T cells in the tumors of long-term pancreatic cancer survivors, with a role for neoantigens in immunotherapy.
Tumor Biology Matters
Dr. Lynn Matrisian of PanCAN, explains that molecular profiling of a pancreatic cancer patient’s tumor can show which treatment will work best.
Pancreatic Cancer Organizations Join in Mourning Aretha Franklin
Let’s Win and the Elvin Howard, Sr. Pancreatic Cancer Advocacy Foundation join in mourning Aretha Franklin, and to raise awareness of pancreatic cancer.
Let’s Win Receives Biden Cancer Initiative FIERCE Award
Let’s Win! Pancreatic Cancer Foundation is the inaugural winner of the Biden Cancer Initiative FIERCE Award for “Leadership through Exemplary and Awesome Purpose (LEAP).”
Let’s Win! Pancreatic Cancer Unveils Spanish-Language Website To Connect Latinos With Pancreatic Cancer Information, Resources, And Community
Let’s Win! Pancreatic Cancer announces a Spanish-language platform to connect the Latino community to pancreatic cancer resources in Spanish.
New Prospective Clinical Study of Blood-Based Early Detection Test
Dr. Rosalie Sears is working with Biological Dynamics to test a new early detection blood assay and platform for pancreatic cancer screening.
Adjuvant Chemotherapy with Modified FOLFIRINOX Regimen Improves Survival
A French clinical trial showed that adjuvant chemotherapy (given after surgery) with modified FOLFIRINOX improves survival of pancreatic cancer patients.
Stereotactic Body Radiation Therapy (SBRT) for Select Pancreatic Cancer Patients
Stereotactic body radiation therapy (SBRT) is increasingly being used to treat locally advanced pancreatic cancer, and make it surgically removable.
Can SBRT Become More Effective?
Radiation oncologist Dr. Todd Aguilera is looking for ways to make SBRT a more effective treatment for pancreatic cancer.
BRCA’s Role in Pancreatic Cancer Investigated
The relationship between BRCA and pancreatic cancer, and how that affects treatment, is the focus of clinical trials looking at PARP inhibitors.
RNA Precision Trial for Pancreatic Cancer Opens At Columbia
Dr. Andrea Califano leads a precision oncology clinical trial of the OncoTreat platform, which looks at proteins to determine treatment.